
Teligent, Inc. TLGT
Teligent, Inc. Cash Conversion Cycle 2011-2026 | TLGT
Annual Cash Conversion Cycle Teligent, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 120 | 132 | 139 | 148 | 143 | 128 | 125 | 130 | 114 | 105 | 111 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 148 | 105 | 127 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Verastem
VSTM
|
38.5 | $ 5.04 | -4.73 % | $ 349 M | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
72.3 | $ 12.41 | -11.1 % | $ 1.88 B | ||
|
Xenon Pharmaceuticals
XENE
|
72.6 | $ 54.48 | -1.89 % | $ 4.24 B | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
ChemoCentryx
CCXI
|
3.1 | - | - | $ 3.74 B | ||
|
Summit Therapeutics
SMMT
|
379 | $ 16.58 | -3.94 % | $ 12.4 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
46.6 | $ 317.36 | -3.29 % | $ 41.6 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
50 | $ 4.29 | -3.6 % | $ 822 M | ||
|
Brickell Biotech
BBI
|
149 | - | -5.38 % | $ 6.06 M | ||
|
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | ||
|
Fusion Pharmaceuticals
FUSN
|
6 | - | - | $ 1.41 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
205 | $ 19.01 | -2.66 % | $ 889 M | ||
|
Завод ДИОД
DIOD
|
-32.7 | - | - | - | ||
|
Фармсинтез
LIFE
|
-15.9 | - | - | - | ||
|
ACADIA Pharmaceuticals
ACAD
|
257 | $ 20.75 | -3.35 % | $ 3.44 B | ||
|
Viela Bio, Inc.
VIE
|
139 | - | - | $ 2.91 B | ||
|
Alkermes plc
ALKS
|
299 | $ 29.39 | -1.77 % | $ 4.84 B | ||
|
AbbVie
ABBV
|
284 | $ 209.4 | -0.81 % | $ 370 B | ||
|
AbCellera Biologics
ABCL
|
173 | $ 3.27 | -2.39 % | $ 977 M | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M |